0.97
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CTSO?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$0.99
Offen:
$0.99
24-Stunden-Volumen:
151.96K
Relative Volume:
0.67
Marktkapitalisierung:
$61.72M
Einnahmen:
$33.79M
Nettoeinkommen (Verlust:
$-18.67M
KGV:
-2.708
EPS:
-0.3582
Netto-Cashflow:
$-19.17M
1W Leistung:
-3.00%
1M Leistung:
-3.00%
6M Leistung:
-18.49%
1J Leistung:
+1.57%
Cytosorbents Corp Stock (CTSO) Company Profile
Firmenname
Cytosorbents Corp
Sektor
Branche
Telefon
973-329-8885
Adresse
305 COLLEGE ROAD EAST, PRINCETON, NJ
Vergleichen Sie CTSO mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
CTSO
Cytosorbents Corp
|
0.97 | 61.72M | 33.79M | -18.67M | -19.17M | -0.3582 |
![]()
ABT
Abbott Laboratories
|
124.44 | 224.21B | 41.95B | 13.40B | 6.35B | 7.65 |
![]()
SYK
Stryker Corp
|
345.80 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
![]()
BSX
Boston Scientific Corp
|
89.70 | 138.89B | 16.75B | 1.85B | 2.37B | 1.25 |
![]()
MDT
Medtronic Plc
|
82.88 | 112.70B | 33.20B | 4.26B | 5.47B | 3.29 |
![]()
EW
Edwards Lifesciences Corp
|
69.36 | 41.63B | 5.72B | 4.17B | 259.90M | 6.97 |
Cytosorbents Corp Stock (CTSO) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2023-09-07 | Eingeleitet | B. Riley Securities | Buy |
2021-10-14 | Fortgesetzt | B. Riley Securities | Buy |
2020-09-17 | Eingeleitet | Jefferies | Buy |
2020-09-01 | Eingeleitet | SVB Leerink | Outperform |
2017-08-08 | Bestätigt | Maxim Group | Buy |
2016-10-26 | Eingeleitet | Aegis Capital | Buy |
2016-05-24 | Eingeleitet | Maxim Group | Buy |
2015-10-29 | Hochstufung | WBB Securities | Speculative Buy → Buy |
2015-05-12 | Bestätigt | MLV & Co | Buy |
2015-04-01 | Bestätigt | MLV & Co | Buy |
2015-03-05 | Eingeleitet | MLV & Co | Buy |
2015-02-25 | Eingeleitet | WBB Securities | Speculative Buy |
2015-01-27 | Bestätigt | H.C. Wainwright | Buy |
Alle ansehen
Cytosorbents Corp Aktie (CTSO) Neueste Nachrichten
CytoSorbents extends Series B Warrants expiration to June 10 - Investing.com
Cytosorbents CorpExtends Expiration Date Of Series B Right Warrants To June 10, 2025SEC Filing - MarketScreener
CytoSorbents Extends Expiration Date of Outstanding Series B Right Warrants - PR Newswire
Cytosorbents (NASDAQ:CTSO) Coverage Initiated at StockNews.com - Defense World
Cytosorbents (NASDAQ:CTSO) Given Buy Rating at D. Boral Capital - Defense World
Cytosorbents Corp Reports Strong Growth Amid Challenges - TipRanks
CytoSorbents Corp Q4 2024 Earnings: EPS Misses at -$0.06, Revenue Falls Short at $9.2 Million - GuruFocus
The Analyst Verdict: CytoSorbents In The Eyes Of 4 Experts - Benzinga
Cytosorbents Corporation (NASDAQ:CTSO) Q4 2024 Earnings Call Transcript - Insider Monkey
CytoSorbents Corp (CTSO) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
CytoSorbents Corp (CTSO) Q4 2024 Earnings Call Highlights: Stron - GuruFocus
CytoSorbents Corporation Reports Strong 2024 Performance - TipRanks
CytoSorbents: Q4 Earnings Snapshot - MySA
Earnings call transcript: Cytosorbents Crp Q4 2024 beats EPS forecast By Investing.com - Investing.com South Africa
Cytosorbents Corp reports results for the quarter ended December 31Earnings Summary - TradingView
Cytosorbents Corp SEC 10-K Report - TradingView
CytoSorbents Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights - TradingView
CYTOSORBENTS Earnings Results: $CTSO Reports Quarterly Earnings - Nasdaq
CytoSorbents Corp (CTSO) Reports Q4 Revenue Between $9.0M and $9 - GuruFocus
Cytosorbents (CTSO) Expected to Post Improved Earnings and Reven - GuruFocus
Insights into CytoSorbents's Upcoming Earnings - Benzinga
Cytosorbents (NASDAQ:CTSO) Now Covered by StockNews.com - Defense World
CytoSorbents Corp (CTSO) Q4 2024 Earnings Report Preview: What t - GuruFocus.com
Cytosorbents (CTSO) Expected to Announce Quarterly Earnings on Monday - Defense World
CytoSorbents Reschedules Earnings Release to March 31, 2025 to Allow Additional Time to Complete Annual Audit - Longview News-Journal
CytoSorbents Q4 Revenue Jumps 25% Despite Earnings DelayKey Metrics Released - StockTitan
Cytosorbents (NASDAQ:CTSO) Share Price Passes Above Two Hundred Day Moving Average – Here’s Why - Defense World
CytoSorbents Stock Price, Quotes and Forecasts | NASDAQ:CTSO - Benzinga
Cytosorbents (NASDAQ:CTSO) shareholders have endured a 78% loss from investing in the stock five years ago - Yahoo Finance
StockNews.com Initiates Coverage on Cytosorbents (NASDAQ:CTSO) - Defense World
CytoSorbents Corp. to Host Earnings Call - ACCESS Newswire
CytoSorbents Corp (CTSO) Q4 2024 Earnings Report Preview: What T - GuruFocus.com
CytoSorbents Corp (CTSO) Q4 2024 Earnings Report Preview: What To Expect - Yahoo Finance
Cytosorbents Corp Reaffirms Preliminary Financial Expectations For Q4 And FY 2024 -March 04, 2025 at 04:52 pm EST - Marketscreener.com
CytoSorbents delays earnings call after VP’s passing - Investing.com India
CytoSorbents Corporation Postpones Earnings Call Following Loss of Vice President and Corporate Controller - Nasdaq
CytoSorbents delays earnings call after VP’s passing By Investing.com - Investing.com Canada
CytoSorbents Delays Earnings But Confirms 25% Growth: What's Behind The Postponement? - StockTitan
StockNews.com Begins Coverage on Cytosorbents (NASDAQ:CTSO) - The AM Reporter
Cytosorbents (NASDAQ:CTSO) Now Covered by Analysts at StockNews.com - Defense World
Cytosorbents (NASDAQ:CTSO) Earns “Buy” Rating from D. Boral Capital - Defense World
Cytosorbents (CTSO) to Release Quarterly Earnings on Thursday - Defense World
When Will CytoSorbents Release Q4 2024 Results? Key Date for Investors - StockTitan
CytoSorbents to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights - Yahoo Finance
CytoSorbents secures $1.6 million from warrant exercises - Investing.com
CytoSorbents Secures $1.6M Capital InjectionWill This Fuel Their FDA Application Success? - StockTitan
Cytosorbents Co. (NASDAQ:CTSO) Sees Significant Increase in Short Interest - Defense World
B. Riley Securities initates Cytosorbents Corp (CTSO) rating to a Buy - Knox Daily
CTSO stock touches 52-week high at $1.6 amid robust annual growth - MSN
Cytosorbents (NASDAQ:CTSO) Stock Passes Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat
Cytosorbents (NASDAQ:CTSO) Stock Passes Above Two Hundred Day Moving Average – Should You Sell? - Defense World
Finanzdaten der Cytosorbents Corp-Aktie (CTSO)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):